People with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are at higher risk of developing infections due to having weakened immune systems.

MBL is a condition where there is an accumulation of abnormal B-cells in the blood. B-cells, also known as B-lymphocytes, are a type of white blood cell that makes antibodies to fight infections.

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

Most people with chronic lymphocytic leukemia (CLL) at the time of diagnosis have no obvious symptoms and are often diagnosed based on the results of a routine blood test.

Receiving a cancer diagnosis is a challenging and emotional experience that can trigger a range of emotions including sadness, anxiousness, worry, anger, disbelief, denial, and confusion.

Small lymphocytic lymphoma (SLL) is a slow-growing, chronic blood cancer involving an abnormal
overgrowth of white blood cells called B-lymphocytes.

Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Fatigue is one of the most common symptoms experienced by those living with CLL and SLL, and it is also commonly overlooked,underreported, and undertreated.